Controlled trial of tamoxifen as a single adjuvant agent in the management of early breast cancer. 'Nolvadex' Adjuvant Trial Organisation.
暂无分享,去创建一个
[1] I. Nenci,et al. Immunocytochemical demonstration of estrogen receptors by monoclonal antibodies in human breast cancer: correlation with estrogen receptor assay by dextran-coated charcoal method. , 1987, Cancer research.
[2] R. Derynck,et al. Evidence that transforming growth factor-β is a hormonally regulated negative growth factor in human breast cancer cells , 1987, Cell.
[3] I. Weinstein,et al. Triphenylethylenes: a new class of protein kinase C inhibitors. , 1986, Journal of the National Cancer Institute.
[4] CONTROLLED TRIAL OF TAMOXIFEN AS SINGLE ADJUVANT AGENT IN MANAGEMENT OF EARLY BREAST CANCER Analysis at Six Years by Nolvadex Adjuvant Trial Organisation , 1985, The Lancet.
[5] I. Christensen,et al. Effects of the antioestrogen tamoxifen on the cell cycle kinetics of the human breast cancer cell line, MCF-7. , 1984, British Journal of Cancer.
[6] H Y Lam,et al. Tamoxifen is a calmodulin antagonist in the activation of cAMP phosphodiesterase. , 1984, Biochemical and biophysical research communications.
[7] S. Cowan,et al. British interlaboratory quality assessment of steroid receptor assays. , 1984, Recent results in cancer research. Fortschritte der Krebsforschung. Progres dans les recherches sur le cancer.
[8] I W Taylor,et al. Cell proliferation kinetics of MCF-7 human mammary carcinoma cells in culture and effects of tamoxifen on exponentially growing and plateau-phase cells. , 1983, Cancer research.
[9] Michael Baum,et al. IMPROVED SURVIVAL AMONGST PATIENTS TREATED WITH ADJUVANT TAMOXIFEN AFTER MASTECTOMY FOR EARLY BREAST CANCER , 1983, The Lancet.
[10] M. Baum,et al. CONTROLLED TRIAL OF TAMOXIFEN AS ADJUVANT AGENT IN MANAGEMENT OF EARLY BREAST CANCER Interim Analysis at Four Years by Nolvadex Adjuvant Trial Organisation , 1983, The Lancet.
[11] D. Barnes,et al. Measurement of oestradiol receptors by five institutions on common tissue samples. , 1978, British Journal of Cancer.
[12] D.,et al. Regression Models and Life-Tables , 2022 .